- Home
- RARE vs MUR Comparison
RARE vs MUR Comparison
Compare RARE & MUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RARE
- MUR
- Stock Information
- Founded
- RARE 2010
- MUR 1950
- Country
- RARE United States
- MUR United States
- Employees
- RARE N/A
- MUR N/A
- Industry
- RARE Biotechnology: Pharmaceutical Preparations
- MUR Oil & Gas Production
- Sector
- RARE Health Care
- MUR Energy
- Exchange
- RARE Nasdaq
- MUR Nasdaq
- Market Cap
- RARE 5.2B
- MUR 4.7B
- IPO Year
- RARE 2014
- MUR N/A
- Fundamental
- Price
- RARE $46.02
- MUR $33.15
- Analyst Decision
- RARE Strong Buy
- MUR Hold
- Analyst Count
- RARE 14
- MUR 13
- Target Price
- RARE $86.79
- MUR $40.92
- AVG Volume (30 Days)
- RARE 947.6K
- MUR 1.5M
- Earning Date
- RARE 11-05-2024
- MUR 11-07-2024
- Dividend Yield
- RARE N/A
- MUR 3.66%
- EPS Growth
- RARE N/A
- MUR N/A
- EPS
- RARE N/A
- MUR 3.09
- Revenue
- RARE $522,745,000.00
- MUR $3,191,294,000.00
- Revenue This Year
- RARE $27.29
- MUR N/A
- Revenue Next Year
- RARE $18.30
- MUR $3.10
- P/E Ratio
- RARE N/A
- MUR $10.62
- Revenue Growth
- RARE 27.44
- MUR N/A
- 52 Week Low
- RARE $37.02
- MUR $30.99
- 52 Week High
- RARE $60.37
- MUR $49.14
- Technical
- Relative Strength Index (RSI)
- RARE 34.61
- MUR 51.24
- Support Level
- RARE $43.04
- MUR $32.37
- Resistance Level
- RARE $53.04
- MUR $33.58
- Average True Range (ATR)
- RARE 2.14
- MUR 0.92
- MACD
- RARE -0.35
- MUR 0.17
- Stochastic Oscillator
- RARE 28.57
- MUR 75.84
About RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi, and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About MUR Murphy Oil Corporation
Murphy Oil is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States.